Editorial

Dear Colleagues, The Viral Hepatitis Journal, which journal three issues a year and publishes qualitative scientific hepatitis articles at the International level, has come end of the year. In our journal in 2016, 4 reviews, 15 articles, 3 case reports, 5 letter to the editors were published. We thank to all authors, reviewers and others for the contributing. We would like to remind you that the Viral Hepatitis Journal has been indexed in Emerging Sources Citation Index (SCI-E). Your articles are both indexing with ESCI and can be accessed as open access. In this issue, there are one review article about “Immunosuppressive Therapy and Hepatitis B Virus Reactivation” and four articles about “Hepatitis B Virus Vaccination Rates among Medical Laboratory Workers: A Multicentered Assessment”, “Seroepidemiology of Hepatitis B Virus Infection in Istanbul: A 20-year Survey” “Real-life Outcomes of Tenofovir Disoproxil Fumarate Monotherapy in Nucleos(t)ide Analogue-naive and Nucleos(t) ide Analogue-experienced Chronic Hepatitis B Patients: A Single-center Experience”, “Interleukin 28B rs12979860 CT, rs12980275 GA, rs8099917 GT and TT genotypes are the Predictors of Rapid Viral Response in Hepatitis C Virus-Infected Patients” and “Hepatitis B Virus Carrying Drug-resistance Compensatory Mutations in Chronically Infected Treatment-naive Patients”. Also; “Acute Viral Hepatitis B with a Severe Clinical Course in Pregnancy: A Case Report”, “An Important Financial Burden: Unnecessary Test Requests for Viral Hepatitis” and “Human Pegivirus and Its Relationship with HIV?”, subjects were included in the letter to the editor in this issue. We expect your contributions with articles, case reports, reviews, and letters to the editor. Best wishes